Jakub Tolar, MD, Pediatric Hematology & Oncology, Minneapolis, MN, University of Minnesota Masonic Children's Hospital

JakubTolarMDPhD

Pediatric Hematology & Oncology Minneapolis, MN

Pediatric Hematologic Oncology

Dean of the University of Minnesota Medical School, Vice President for Clinical Affairs, University of Minnesota- Twin Cities

Dr. Tolar is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tolar's full profile

Already have an account?

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2000 - 2003
  • University of Minnesota
    University of MinnesotaResidency, Pediatrics, 1997 - 2000
  • University of MinnesotaPh.D., Molecular, Cellular & Developmental Biology and Genetics, 1992 - 1996
  • Charles University in Prague Faculty of Medicine
    Charles University in Prague Faculty of MedicineClass of 1990, Summa Cum Laude
  • Na Vitezne PlaniB.S., Examination of Maturity, Summa Cum Laude, 1980 - 1984

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1999 - 2022
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Best Doctors in America BestDoctors.com, 2012, 2017-2018
  • Top Doctors Minneapolis St. Paul Magazine, 2010, 2012-2018
  • Elected to Academic Health Center's Academy for Excellence in Health Research University of Minnesota, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Thymic Epithelial Cell Support of Thymopoiesis Does Not Require Klotho  
    Bruce R Blazar, Heather E Stefanski, Sarah L Parker, Jakub Tolar, The Journal of Immunology
  • Outcome of Haematopoietic Stem Cell Transplantation in Dyskeratosis Congenita*  
    Jakub Tolar, MD, British Journal of Haematology
  • Prediction of DNA-binding propensity of proteins by the ball-histogram method  
    Szaboova A, KuZelka O, Morales E, Zelezny F, Tolar J, Lect Notes Comput Sc, 1/1/2011
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Plasma and intracellular population pharmacokinetic analysis of fludarabine in pediatric allogeneic hematopoietic cell transplant (alloHCT) recipients.
    Long-Boyle J, Sambol N, Dvorak CC, Cowan MJ, Lee S, Huang LS, Horn B, Stricherz M, Tolar J, Orchard P, Jacobson P, Aweeka F, Biol Blood Marrow Transplant, 1/1/2014
  • Toxic epidermal necrolysis (TEN) in recessive dystrophic epidermolysis bullosa status post hematopoietic stem cell transplant.
    Sajic D, Hook K, Tolar J, 89th Canadian Dermatology Association Annual Conference, 1/1/2014
  • Effects of vitronectin on neural differentiation and proliferation of human iPSC’s in 3D cell culture.
    Venhuizen S, Lindborg B, Haider K, Ulrich C, Vegoe A, Subramaniam S, Brekke JH, Dutton J, Tolar J, O’Brien TD, Cornell University Merial-NIH Veterinary Scholars Symposium, 1/1/2014
  • Join now to see all

Lectures

  • Reduced Intensity Conditioned Bone Marrow Transplant with Post-Transplant Cyclophosphamide and Donor-Derived Mesenchymal Stromal Cell Infusions for Recessive Dystrophi... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Cellular Therapy: Concepts and Plans 
    Osaka, Japan - 1/14/2014
  • Immunity in Genetic Disorders, Cancer, and Bone Marrow Transplant 
    University of Minnesota Children’s Hospital, Minneapolis, MN - 1/11/2014
  • Join now to see all

Other

  • Biological characterization of naturally occurring mutations in an oncogenic variant of human papillomavirus type 11, PhD thesis, directed by Anthony J. Faras, PhD. 
    Tolar J
    1/1/1996

Press Mentions

  • ‘This Is Not an Empty Disneyland Kind of Hope’: U of M Dr. Jakub Tolar Talks COVID Treatments
    ‘This Is Not an Empty Disneyland Kind of Hope’: U of M Dr. Jakub Tolar Talks COVID TreatmentsOctober 25th, 2020
  • University of Minnesota Completes $83M Health Sciences Venue
    University of Minnesota Completes $83M Health Sciences VenueOctober 22nd, 2020
  • Reopening Rochester's Economy Goes Beyond the Idea of Lives vs. Livelihoods
    Reopening Rochester's Economy Goes Beyond the Idea of Lives vs. LivelihoodsApril 24th, 2020
  • Join now to see all

Other Languages

  • Czech

Hospital Affiliations